Konstantine T Kalogeras
Overview
Explore the profile of Konstantine T Kalogeras including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
53
Citations
1815
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Koletsa T, Kotoula V, Koliou G, Manousou K, Chrisafi S, Zagouri F, et al.
Cancer Immunol Immunother
. 2020 Apr;
69(8):1549-1564.
PMID: 32303794
Background: Tumor-infiltrating lymphocytes (TILs) and their subsets contribute to breast cancer prognosis. We investigated the prognostic impact of CD3+, CD8+ and FOXP3+ TILs in patients with early intermediate/high-risk breast cancer...
2.
Razis E, Kalogeras K, Kotsantis I, Koliou G, Manousou K, Wirtz R, et al.
Clin Breast Cancer
. 2019 Nov;
20(1):e36-e53.
PMID: 31699671
Background: Chemokines, cytokines in the immune microenvironment of tumors, may be associated with patient outcome. We assessed the impact of CXCL13 and CXCL9 on disease-free (DFS) and overall survival (OS),...
3.
Economopoulou P, Kotoula V, Koliou G, Papadopoulou K, Christodoulou C, Pentheroudakis G, et al.
Transl Oncol
. 2019 Mar;
12(5):739-748.
PMID: 30877976
Background: Src, CDKN1B, and JAK2 play a crucial role in the coordination of cell signaling pathways. In the present study, we aim to investigate the prognostic significance of these biomarkers...
4.
Carvajal-Hausdorf D, Patsenker J, Stanton K, Villarroel-Espindola F, Esch A, Montgomery R, et al.
Clin Cancer Res
. 2019 Feb;
25(10):3054-3062.
PMID: 30796036
Purpose: Imaging mass cytometry (IMC) uses metal-conjugated antibodies to provide multidimensional, objective measurement of protein targets. We used this high-throughput platform to perform an 18-plex assessment of HER2 ICD/ECD, cytotoxic...
5.
Koutras A, Lazaridis G, Koliou G, Kouvatseas G, Christodoulou C, Pectasides D, et al.
PLoS One
. 2018 Dec;
13(12):e0207707.
PMID: 30521571
In the current study, we performed a complete analysis, with four different methods, of all four HER family receptors, in a series of patients with metastatic breast cancer treated with...
6.
Karavasilis V, Samantas E, Koliou G, Kalogera-Fountzila A, Pentheroudakis G, Varthalitis I, et al.
Target Oncol
. 2018 Nov;
13(6):715-724.
PMID: 30488350
Background: The prognosis of patients with advanced pancreatic cancer is dismal, and there is a need for novel and effective treatments. Objectives: Tο determine the maximum tolerated dose (MTD) and...
7.
Christodoulou C, Oikonomopoulos G, Koliou G, Kostopoulos I, Kotoula V, Bobos M, et al.
Cancer Genomics Proteomics
. 2018 Oct;
15(6):461-471.
PMID: 30343280
Background: Trastuzumab is a monoclonal antibody against HER2-positive breast cancer. Despite improving the natural history of the disease, there is a number of patients who are resistant to it, whereas...
8.
Tsiatas M, Kalogeras K, Manousou K, Wirtz R, Gogas H, Veltrup E, et al.
Cancer Med
. 2018 Sep;
7(10):5066-5082.
PMID: 30240146
Background: Tumor-infiltrating lymphocytes (TILs) have been shown to be of prognostic value in several cancer types. In early breast cancer, TILs have a prognostic utility, as well, especially in HER2-positive...
9.
Goussia A, Simou N, Zagouri F, Manousou K, Lazaridis G, Gogas H, et al.
PLoS One
. 2018 Aug;
13(7):e0200302.
PMID: 30063723
Several studies support an important role of angiogenesis in breast cancer growth and metastasis. The main objectives of the study were to investigate the immunohistochemical expression of vascular endothelial growth...
10.
Schmidt M, Weyer-Elberich V, Hengstler J, Heimes A, Almstedt K, Gerhold-Ay A, et al.
Breast Cancer Res
. 2018 Feb;
20(1):15.
PMID: 29482642
Background: The clinical importance of tumor-infiltrating cluster of differentiation 4 (CD4) T cells is incompletely understood in early breast cancer. We investigated the clinical significance of CD4, forkhead box P3...